chr19-41756906-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_002483.7(CEACAM6):āc.371T>Cā(p.Val124Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000026 in 1,613,782 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_002483.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CEACAM6 | NM_002483.7 | c.371T>C | p.Val124Ala | missense_variant | 2/6 | ENST00000199764.7 | |
LOC112268252 | XR_002958447.2 | n.1511A>G | non_coding_transcript_exon_variant | 2/2 | |||
CEACAM6 | XM_011526990.3 | c.371T>C | p.Val124Ala | missense_variant | 2/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CEACAM6 | ENST00000199764.7 | c.371T>C | p.Val124Ala | missense_variant | 2/6 | 1 | NM_002483.7 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152096Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000439 AC: 11AN: 250852Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135540
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1461568Hom.: 0 Cov.: 33 AF XY: 0.0000138 AC XY: 10AN XY: 727076
GnomAD4 genome AF: 0.000145 AC: 22AN: 152214Hom.: 0 Cov.: 31 AF XY: 0.000161 AC XY: 12AN XY: 74422
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 05, 2021 | The c.371T>C (p.V124A) alteration is located in exon 2 (coding exon 2) of the CEACAM6 gene. This alteration results from a T to C substitution at nucleotide position 371, causing the valine (V) at amino acid position 124 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at